155 related articles for article (PubMed ID: 4768206)
21. [Current treatment of the Parkinsonian syndrome].
Voiculescu V
Neurol Psihiatr Neurochir; 1973; 18(6):519-23. PubMed ID: 4790485
[No Abstract] [Full Text] [Related]
22. [Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results].
De Divitiis E; Cerillo A; Tata MR; Decina A
Acta Neurol (Napoli); 1973; 28(2):208-12. PubMed ID: 4709076
[No Abstract] [Full Text] [Related]
23. [Treatment of Parkinson's syndrome using L-dopa. 2].
Glabb J; Hübner W; Glabb S
Z Arztl Fortbild (Jena); 1973 Aug; 67(15):745-53. PubMed ID: 4594383
[No Abstract] [Full Text] [Related]
24. [Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].
Gattringer B; Steinhäusl H
Wien Med Wochenschr; 1972 Jun; 122(25):369-71. PubMed ID: 4558132
[No Abstract] [Full Text] [Related]
25. [Familial syndrome with parkinsonian tremor and anosmia and its therapy with L-dopa associated with a decarboxylase inhibitor].
Constantinidis J; de Ajuriaguerra J
Therapeutique; 1970 Mar; 46(3):263-9. PubMed ID: 5422192
[No Abstract] [Full Text] [Related]
26. [Dopa and decarboxylase inhibitors in Parkinson's disease].
Pakkenberg H
Ugeskr Laeger; 1974 Feb; 136(7):377. PubMed ID: 4821980
[No Abstract] [Full Text] [Related]
27. [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].
Schneider E; Fischer PA; Jacobi P; Maxion H
Arch Psychiatr Nervenkr (1970); 1973 Mar; 217(1):95-112. PubMed ID: 4695662
[No Abstract] [Full Text] [Related]
28. [Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
Siegfried J; Klaiber R; Perret E; Ziegler WH
Dtsch Med Wochenschr; 1969 Dec; 94(52):2678-81. PubMed ID: 4903342
[No Abstract] [Full Text] [Related]
29. Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.
Fermaglich J
Med Ann Dist Columbia; 1974 Dec; 43(12):587-91. PubMed ID: 4532167
[No Abstract] [Full Text] [Related]
30. [L-dopa + peripheral decarboxylase antagonist].
Wiesel FA
Lakartidningen; 1975 Oct; 72(43):4173. PubMed ID: 1177632
[No Abstract] [Full Text] [Related]
31. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
Birkmayer W; Linauer W; Mentasti M; Riederer P
Wien Med Wochenschr; 1974 Jun; 124(22):340-4. PubMed ID: 4275492
[No Abstract] [Full Text] [Related]
32. Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.
Rinne UK; Sonninen V; Sirtola T
Z Neurol; 1972; 202(1):1-20. PubMed ID: 4114458
[No Abstract] [Full Text] [Related]
33. [Therapy of Parkinson's syndrome with L-dopa only and in combination with a decarboxylase inhibitor. A comparison].
Feise G; Paal G
Nervenarzt; 1974 Mar; 45(3):126-32. PubMed ID: 4832035
[No Abstract] [Full Text] [Related]
34. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Court J; Kase JC; Mena I; Palacios E
Rev Med Chil; 1973 Jun; 101(6):452-5. PubMed ID: 4764560
[No Abstract] [Full Text] [Related]
35. [Results after 3 to 5 years of treatment of 219 cases of Parkinson's syndrome treated by L-Dopa and an L-Dopa -decarboxylase inhibitor combination].
Boudin G; Pepin B; Guillard A; Godlewski S; Fabiani JM; Haguenau M
Rev Neurol (Paris); 1974; 130(7-8):273-84. PubMed ID: 4217929
[No Abstract] [Full Text] [Related]
36. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)].
Mazza C; Buffatti PF; Bazzan A; Lion P
Fracastoro; 1970; 63(5):768-73. PubMed ID: 5519378
[No Abstract] [Full Text] [Related]
37. [Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].
Matussek N; Benkert O; Schneider K; Otten H; Pohlmeier H
Arzneimittelforschung; 1970 Jul; 20(7):934-5. PubMed ID: 4918921
[No Abstract] [Full Text] [Related]
38. [Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects].
Geissbuhler F; Eisenring JJ; Friedli P; Bartholini G; Tissot R
Encephale; 1972; 61(2):127-48. PubMed ID: 4634903
[No Abstract] [Full Text] [Related]
39. [Treatment of the parkinsonian syndrome with L-dopa and amantadine].
Pendefunda GH; Pollingher B; Stefanache F; Gavril A; Oprişan C; Merling M; Nemţeanu E; Ciuntu M; Koropitzer I
Neurol Psihiatr Neurochir; 1973; 18(6):559-68. PubMed ID: 4790488
[No Abstract] [Full Text] [Related]
40. [Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
Streifler M; Vardi J; Kesten M
Harefuah; 1972 Nov; 83(9):362-4. PubMed ID: 4669737
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
